An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

NCT01269021 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy (IgAN)

Interventions

DRUG: mycophenolate mofetil plus lower dose of Prednisone
DRUG: Prednisone in full dose

Sponsor

Zhi-Hong Liu, M.D.